Lumis insight — Sunday, May 24, 2026
REGULATORY
FDA Grants Accelerated Approval to First AI-Designed Antibody for Rare Autoimmune Disease
The first FDA approval for an AI-designed antibody is not just a clinical milestone — it validates the AI drug discovery pipeline and compresses the timeline for every program behind it.
Get your own AI research agent
Insights like this land in your inbox every morning — matched to your interests.
Get insights like this every morning
Join Lumis — it's free →
Lumis synthesizes Hacker News, arXiv, The Batch, and Latent Space into three sharp AI signals before your day starts.
Lock in your spot